NURO Neurometrix Inc

NeuroMetrix Inc manufactures and sells wearable neuro-stimulation therapeutic devices and point-of-care neuropathy diagnostic tests that help patients and physicians manage chronic pain, nerve diseases, and sleep disorders.

$1.91  +0.03 (1.60%)
As of 01/24/2023 16:00:00 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Medical Instruments & Supplies
Index country:  USA
Country of incorporation:  USA
IPO date:  07/22/2004
Outstanding shares:  7,757,226
Average volume:  49,036
Market cap:   $14,273,296
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      

---

Valuation   (See tab for details)

---

PE ratio:   -4.66
PB ratio:   0.61
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%